Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 6/20 | 0.49 |
| ▸ | PPARG | P37231 | 2/20 | 0.46 |
| ▸ | PPARA | Q07869 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.42 |
| ▸ | LTA4H | P09960 | 2/20 | 0.42 |
| ▸ | KAT6A | Q92794 | 1/20 | 0.41 |
| ▸ | PPARD | Q03181 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | DRD2 | P14416 | 1/20 | 0.40 |
| ▸ | DRD4 | P21917 | 1/20 | 0.40 |
| ▸ | DRD3 | P35462 | 1/20 | 0.40 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.40 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30833003 | 0.85 | FFAR1 (0.49) | FFAR1PPARGPPARALTA4HMAPT | |
| SCHEMBL30833000 | 0.85 | FFAR1 (0.55) | FFAR1PPARGPPARAKMT2APPARD | |
| SCHEMBL30833002 | 0.84 | FFAR1 (0.50) | FFAR1PPARGPPARAPPARDDRD2 | |
| SCHEMBL10682048 | 0.83 | KCNA3 (0.44) | FFAR1PPARGPPARAPPARDDRD2 | |
| SCHEMBL16575404 | 0.82 | ADORA3 (0.51) | KMT2AADORA3LTA4HMAPTMEN1 | |
| SCHEMBL10676777 | 0.81 | PPARG (0.43) | FFAR1PPARGPPARAPPARDDRD2 | |
| SCHEMBL10682461 | 0.81 | PPARG (0.43) | FFAR1PPARGPPARAPPARDDRD2 | |
| SCHEMBL10674265 | 0.81 | F2 (0.47) | PPARGPPARAPPARDDRD2DRD4 | |
| SCHEMBL10681206 | 0.80 | F2 (0.48) | PPARGPPARA | |
| SCHEMBL30832999 | 0.79 | FFAR1 (0.45) | FFAR1PPARGPPARALTA4HMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11905230-B2 | Phenoxyacetic acid derivatives, preparation method thereof and use thereof as medicament | CHINA PHARMACEUTICAL UNIVERSITY (CN) | 2024-02-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11905230-B2 | Phenoxyacetic acid derivatives, preparation method thereof and use thereof as medicament | SLC5A1, PYGL, GPR119 | FFAR1 57/4885PPARG 39/4885PPARA 11/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.